Steve Sisolak Governor State of Nevada Richard Whitley MS Director Department of Health and Human Services Lisa Sherych MBA Administrator Division of Public and Behavioral Health Ihsan Azzam PhD MD ID: 1014165
Download Presentation The PPT/PDF document "Data Reporting for CCBHC" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. Data Reportingfor CCBHCSteve SisolakGovernorState of NevadaRichard Whitley, MSDirectorDepartment of Health and Human ServicesLisa Sherych, MBAAdministratorDivision of Public and Behavioral HealthIhsan Azzam, PhD, MDChief Medical OfficerDivision of Public and Behavioral Health
2. OutlineIntroductionOverviewMeasure SummaryTimelineSummary
3. IntroductionJames KuzhippalaCCBHC Epidemiologist Consultantjkuzhippala@tmcc.eduJodie TonkinManagement Analyst IIIjtonkin@dhcfp.nv.gov
4. OverviewPurposeThis training and manual provides the specifications for and general information related to quality measures and other metrics developed to be used at the provider level by Certified Community Behavioral Health Clinics (CCBHCs).
5. OverviewWhat we need?Electronic Health RecordsMedicaid ClaimsEligibilityPharmacy Data
6. Measure SummaryMeasureDescriptionI-EVAL-ATime to Initial Evaluation (% getting evaluation with 10 days)I-EVAL-BTime to Initial Evaluation (average days until evaluation)BMI-SFPreventive Care and Screening: Body Mass Index Screening and Follow-UpWCC-BHBody Mass Index Assessment for Children/AdolescentsTSCTobacco Use: Screening & Cessation InterventionASCUnhealthy Alcohol Use: Screening & Brief CounselingSRA-BH-CChild and Adolescent Major Depressive Disorder (MDD): Suicide Risk AssessmentSRA-AAdult Major Depressive Disorder (MDD): Suicide Risk AssessmentCDF-BHScreening for Clinical Depression and Follow-Up PlanDEP-REM-12Depression Remission at Twelve MonthsHOUHousing StatusPECPatient Experience of Care SurveyMeasureDescriptionY/FECYouth/Family Experience Care SurveyFUMFollow-up After Emergency Department Visit for Mental IllnessFUAFollow-up After Emergency Department Visit for Alcohol and Other Drug DependencePCR-BHPlan All-Cause Readmissions RateSSDDiabetes Screening for People with Schizophrenia or Bipolar Disorder who are using Antipsychotic MedicationsSAA-BHAdherence to Antipsychotic Medications for Individuals with SchizophreniaFUH-BHFollow-Up After Hospitalization for Mental IllnessADD-BHFollow-Up Care for Children Prescribed Attention-Deficit Hyperactivity Disorder MedicationAMM-BHAntidepressant Medication ManagementIET-BHInitiation and Engagement of Alcohol and Other Drug Dependence Treatment
7. Measure SummaryMeasureDescriptionI-EVAL-ATime to Initial Evaluation (% getting evaluation with 10 days)I-EVAL-BTime to Initial Evaluation (average days until evaluation)BMI-SFPreventive Care and Screening: Body Mass Index Screening and Follow-UpWCC-BHBody Mass Index Assessment for Children/AdolescentsTSCTobacco Use: Screening & Cessation InterventionASCUnhealthy Alcohol Use: Screening & Brief CounselingSRA-BH-CChild and Adolescent Major Depressive Disorder (MDD): Suicide Risk AssessmentSRA-AAdult Major Depressive Disorder (MDD): Suicide Risk AssessmentCDF-BHScreening for Clinical Depression and Follow-Up PlanDEP-REM-12Depression Remission at Twelve MonthsHOUHousing StatusPECPatient Experience of Care SurveyMeasureDescriptionY/FECYouth/Family Experience Care SurveyFUMFollow-up After Emergency Department Visit for Mental IllnessFUAFollow-up After Emergency Department Visit for Alcohol and Other Drug DependencePCR-BHPlan All-Cause Readmissions RateSSDDiabetes Screening for People with Schizophrenia or Bipolar Disorder who are using Antipsychotic MedicationsSAA-BHAdherence to Antipsychotic Medications for Individuals with SchizophreniaFUH-BHFollow-Up After Hospitalization for Mental IllnessADD-BHFollow-Up Care for Children Prescribed Attention-Deficit Hyperactivity Disorder MedicationAMM-BHAntidepressant Medication ManagementIET-BHInitiation and Engagement of Alcohol and Other Drug Dependence Treatment
8. Manual WalkthroughDataset DefinitionsAllowable Services GridMeasure Technical SpecificationsElectronic Health Record Variables
9. Dataset Definitions
10. Allowable Services Grid
11. Measure Technical Specifications
12. Measure Technical Specifications
13. Measure Technical Specifications
14. Measure Technical Specifications
15. Measure Technical Specifications
16. Measure Technical Specifications
17. Measure Technical Specifications
18. Electronic Health Record Variables
19. Electronic Health Record Variables
20. Electronic Health Record Variables
21. Formats: Fixed Width or CSVFixed Width:0123456789003/15/202001/01/198012/31/201901/15/2020 6815011 4N3YN 5201 CSV: 01234567890,03/15/2020,01/01/1980,12/31/2019,01/15/2020,68,150,1,1,,4,N,3,Y,N,,,,5,2,01,,,,,
22. SRA-BH-CChild and Adolescent Major Depressive Disorder (MDD): Suicide Risk AssessmentThe percentage of patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder with an assessment for suicide risk.
23. Measure Technical Specifications
24. Measure Technical Specifications
25. Measure Technical Specifications
26. SRA-AAdult Major Depressive Disorder (MDD): Suicide Risk AssessmentThe percentage of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified.
27. Measure Technical Specifications
28. Measure Technical Specifications
29. Measure Technical Specifications
30. PCR-BHPlan All-Cause Readmissions RateFor patients aged 18 and older the number of acute inpatient stays during the measurement year that were followed by an unplanned acute readmission for any diagnosis within 30 days.
31. Measure Technical Specifications
32. Measure Technical Specifications
33. Measure Technical Specifications
34. SAA-BHAdherence to Antipsychotic Medications for Individuals with SchizophreniaThe percentage of patients ages 19 to 64 during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.
35. Measure Technical Specifications
36. Measure Technical Specifications
37. Measure Technical Specifications
38. Measure Technical Specifications
39. Measure Technical Specifications
40. FUH-BHFollow-Up After Hospitalization for Mental IllnessThe percentage of discharges for patients age 6 and older who were hospitalized for treatment of selected mental illness diagnoses and who had an outpatient visit, an intensive outpatient encounter, or partial hospitalization with a mental health practitioner. This includes: (1) the percentage of discharges for which the patient received follow-up within 30 days of discharge and (2) the percentage of discharges for which the patient received follow-up within 7 days of discharge.
41. Measure Technical Specifications
42. Measure Technical Specifications
43. Measure Technical Specifications
44. Measure Technical Specifications
45. Measure Technical Specifications
46. Measure Technical Specifications
47. IET-BHInitiation and Engagement of Alcohol and Other Drug Dependence TreatmentThe percentage of patients age 13 and older with a new episode of alcohol or other drug (AOD) dependence who received the following:Initiated treatment through an inpatient AOD admission, outpatient visit, intensive outpatient encounter, or partial hospitalization within 14 days of the diagnosis.Initiated treatment and who had two or more additional services with a diagnosis of AOD within 30 days of the initiation visit.
48. Measure Technical Specifications
49. Measure Technical Specifications
50. Measure Technical Specifications
51. Measure Technical Specifications
52. TimelineData TestingBi-WeeklyData MeetingsBi-WeeklyData SubmissionsQuarterly
53. Contact InformationJames KuzhippalaCCBHC Epidemiologist Consultantjkuzhippala@tmcc.eduJodie TonkinManagement Analyst IIIjtonkin@dhcfp.nv.gov